GabrielliRSianiRSmedileG, et al.Isolated popliteal artery lesion due to giant cell vasculitis post COVID-19 mRNA vaccine and COVID-19 asymptomatic infection. Vascular2022; 30: 17085381221126234. DOI: 10.1177/17085381221126234.
2.
Riera-MartìNRomaniJCalvetJ. SARS-CoV-2 infection triggering a giant cell arteritis. Med Clin (Engl Ed.)2021; 156: 253–254.
3.
MursiAMMirghaniHOElbeialyAA. A case report of post COVID19 giant cell arteritis and polymyalgia rheumatica with visual loss. Clin Med Insights Case Rep2022; 15: 1–3.
4.
ManzoCCastagnaARuotoloG. Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica?Jt Bone Spine2021; 88: 105150.
5.
OdaRInagakiTIshikaneM, et al.Case of adult large vessel vasculitis after SARS-CoV-2 infection. Ann Rheum Dis2020; 79: annrheumdis-2020-218440. DOI: 10.1136/annrheumdis-2020-218440.
6.
VargaZFlammerJASteigerP, et al.Endothelial cell infection and endotheliitis in COVID-19. Lancet2020; 395: 1417–1418.
SilvestriVRecchiaGE. Aortic Pathology during COVID-19 pandemics. Clinical reports in literature and open questions on the two co-occurring conditions. Ann Vasc Surg2021; 75: 109–119.
9.
MettlerCTerrierBTreluyerJM, et al.Risk of systemic vasculitis following mRNA COVID-19 vaccination: a pharmacovigilance study. Rheumatology2022; 61: keac323. DOI: 10.1093/rheumatology/keac323.
10.
MettlerCJonville-BeraAPGrandvuilleminA, et al.Risk of giant cell arteritis and polymyalgia rheumatica following COVID-19 vaccination: a global pharmacovigilance study. Rheumatology2022; 61: 865–867.
11.
LiozonEParreauSFillouxM, et al.Giant cell arteritis or polymyalgia rheumatica after influenza vaccination: a study of 12 patients and a literature review. Autoimmun Rev2021; 20: 102732.
12.
MejrenASØrensenCMGormsenLC, et al.Large-vessel giant cell arteritis after COVID-19 vaccine. Scand J Rheumatol2022; 51: 154–155.
13.
OttavianiSJugePAForienM, et al.Polymyalgia rheumatica following COVID-19 vaccination: a case-series of ten patients. Jt Bone Spine2022; 89: 105334.
14.
ManzoCCastagnaANataleM, et al.Answer to Cadiou et al. “SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID-19 vaccine shot as a trigger?”. Jt Bone Spine2021; 89: 105284.
15.
AnzolaAMTrivesLMartinez-BarrioJ, et al.New-onset giant cell arteritis following COVID-19 mRNA (BioNTech/Pfizer) vaccine: a double-edged sword?Clin Rheumatol2022; 41: 1623–1625.
16.
SauretAStievenartJSmetsP, et al.Case of giant cell arteritis after SARS-CoV-2 vaccination: a particular phenotype?J Rheumatol2022; 49: 120.
17.
GrebCSAouhabZSisbarroD, et al.A case of giant cell arteritis presenting after COVID-19 vaccination: is it just a coincidence?Cureus2022; 14: e21608.
18.
GambichlerTKrogiasCTischoffI, et al.Bilateral giant cell arteritis with skin necrosis following SARS-CoV-2 vaccination. Br J Dermatol2022; 186: e83.
19.
CadiouSPerdrigerAArdoisS, et al.SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID-19 vaccine shot as a trigger? comment on: “Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica?” by Manzo et al. joint bone spine 2021. Jt Bone Spine2022; 89: 105282.
20.
KaulenLDDoubrovinskaiaSMooshageC, et al.Neurological autoimmune diseases following vaccinations against SARS-CoV-2: a case series. Eur J Neurol2022; 29: 555–563.
21.
Szydelko-PaskoUPrzezdziecka-DolykJKrecickaJ, et al.Arteritic anterior ischemic optic neuropathy in the course of giant cell Arteritis after COVID-19. Am J Case Rep2022; 23: e933471.
22.
SimaoLMessiasA. Giant cell arteritis during COVID-19 pandemic. Arq Bras Oftalmol2021; 84: 515–516.
23.
JonathanGLScottFMMatthewKD. A case of post-COVID-19-associated paracentral acute middle maculopathy and giant cell arteritis-like vasculitis. J Neuroophthalmol2021; 41: 351–355.
